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Among the bacterial pathogens Mycobacterium leprae
uniquely invade differentiated Schwann cells, the glial
cells of the adult peripheral nervous system (PNS), and
eventually cause neurological injury, the hallmark of clin-
ical leprosy. Our studies on the cell biology of Schwann
cell infection with M. leprae have contributed to an under-
standing of the early stage of infection and the life cycle of
M. leprae within the PNS. Myelinated and non-myelinated
Schwann cells, the two major glial cell types in the PNS,
show distinct functional responses to M. leprae infection.
Although M. leprae binds to both these cell types, it is the
non-myelinated or myelin-free Schwann cells that are
highly susceptible to M. leprae invasion and preferentially
harbor M. leprae. On the other hand, myelinated Schwann
cells, the abundant phenotype in the adult PNS, are
largely resistant to M. leprae invasion. Interestingly, lep-
rosy bacteria have evolved to generate a myelin-free
Schwann cell pool during early infection by inducing
demyelination and cell proliferation. We provide evi-
dence that M. leprae achieve this by using a major
Schwann cell signaling system that comprises of axonal
ligand neuregulin-1 and its receptors, ErbB2 and ErbB3
that play critical roles during Schwann cell development
and myelination. We have shown that extracellular M. lep-
rae directly bind to ErbB2 receptor tyrosine kinase on
myelinated Schwann cells in an atypical manner that does
not involve usual dimerization with its partner ErbB3;
activated ErbB2 transduces the downstream Ras-Raf-Mek-
Erk signaling and subsequently causes demyelination. In
non-myelinating Schwann cells, which are quiescent in
adult peripheral nerves, M. leprae use somewhat different
tactics since they can efficiently invade this phenotype;
intracellular M. leprae cause these quiescent Schwann cells
to re-enter the cell cycle by inducing the Erk1/2 signaling
not by canonical Ras-Raf-Mek pathway, but via a novel
signaling involving PKC-epsilon and LCK pathway. In this
manner, M. leprae eventually generate a myelin-free cell
population susceptible to infection. We also address how
intracellular M. leprae maintain infected Schwann cells in
myelin-free stage, since de-differentiated cells usually
undergo re-differentiation and remyelination following
nerve injury. We found that intracellular M. leprae inhibit
the myelination program of Schwann cells by turning off
the myelin gene transcription. One of the mechanisms by
which M. leprae downregulate myelin gene expression is
by inhibiting a novel nuclear signaling by the cytoplasmic
domain of ErbB3, which we found to function as a puta-
tive transcriptional activator for the major myelin gene
Mpz. Together, these findings suggest that M. leprae use
Schwann cell signaling mechanisms for bacterial survival
within the PNS. Understanding these cellular mecha-
nisms in details will aid in developing novel therapeutics
and/or diagnostics to prevent the nerve damage at the
early stage of M. leprae infection. Importantly, these stud-
ies are also likely to provide new insights into our under-
standing of the biology of Schwann cells.
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